-

Best Medical International Signs a Memorandum of Understanding with University of Wisconsin Medical Radiation Research Center (UWMRRC) to Develop Revolutionary New Carbon Therapy

WASHINGTON--(BUSINESS WIRE)--Best Medical International and Best Particle Therapy of TeamBest Companies, have recently entered into a Memorandum of Understanding (MOU) with the University of Wisconsin Medical Radiation Research Center (UWMRRC).

Best Particle Therapy will be introducing their unique 400 MeV ion Rapid Cycling Medical Synchrotron (iRCMS) with Variable Energy, Heavy Ion Treatment Technologies, offering Proton-to-Carbon Heavy Ion, for Highly Precise, Conformal and Hypo-Fractionated Radiation Therapy. This will be the most advanced new technology for Cancer Therapy, enhancing the cure for many millions of Cancer patients, who do not have this option currently.

The advantages of the Best 400 MeV iRCMS are:

  • Intrinsically small beams – facilitating beam delivery with precision for the most conformal radiation therapy
  • Hypo-fractioned radiation therapy
  • Small beam size – small magnets, light gantries – smaller footprint
  • Highly efficient single turn extraction – less shielding
  • Flexibility – heavy ion beam therapy (protons and/or carbon), beam delivery modalities.

In partnership with Best Cure Foundation (BCF), TeamBest Companies will set up a Hub-and-Spoke Model of Healthcare Delivery System, using Express and Mobile Clinics, linked to General and Multi-Specialty Medical Centers, using all of TeamBest’s new and advanced technologies globally.

University of Wisconsin and Best Medical are excited about the collaboration, as this brings much needed carbon ion therapy to Midwestern states such as Illinois, Wisconsin, Indiana, etc.

For more information, please visit: www.teambest.com

U.S. Office (HQ): 7643 Fullerton Road, Springfield, Virginia 22153 USA

Contacts

Krishnan Suthanthiran • President & Founder
TeamBest Companies & Best Cure Foundation
+1 703-451-2378 •
krish@teambest.com

More News From TeamBest Companies

To Leaders of Canadian First Nations and Federal/Provincial Governments—Fueling the Future with Kitsault Energy

WASHINGTON--(BUSINESS WIRE)--In 2013, Dr. Suthanthiran, President/Founder of TeamBest Global Companies, announced his dedicated energy pipeline corridor/export port/terminal to carry all of Canada’s energy products to Kitsault, BC, Canada, a town owned by Suthanthiran, northwest of Prince Rupert, BC. Suthanthiran, a healthcare professional, has devoted over fifty years to cheering, helping, and saving lives daily. The dedicated pipeline corridor is now a reality, w/multiple pipelines approved a...

Best Vascular/Novoste Celebrates 24th Anniversary of Vascular Brachytherapy Approval & Use of by US FDA

WASHINGTON--(BUSINESS WIRE)--It’s been over 30 years since the first vascular brachytherapy (VBT) animal experiments and human clinical trials were performed and 24 years since the approval of VBT for human clinical use for the treatment of in-stent coronary artery restenosis by the US FDA on November 3, 2000. Dr. Paul Teirstein, at Scripps Clinic in La Jolla, California, in collaboration with Virginia-based Best Medical International (BMI), began the first randomized, double-blind human clinic...

BCF, BREF and TBG Companies Seek Global Financial Support to Establish 1000s of Best Cure Pro Health and Medical Centers

WASHINGTON--(BUSINESS WIRE)--Dr. Krishnan Suthanthiran is the Founder and President of the Best Cure Foundation (BCF), a non-profit 501(c)(3) corporation established in Springfield, Virginia, USA, in 2007. He also established the Brachytherapy Research & Education Foundation (BREF) as a non-profit in Springfield, Virginia, USA, in 1987. Additionally, Suthanthiran founded TeamBest Global (TBG) Companies in 1977 and has acquired several companies over the last 20 years. Suthanthiran's journey...
Back to Newsroom